Alcohol‐Associated Liver Disease: East Versus West
Phunchai Charatcharoenwitthaya, Suthat Liangpunsakul, Teerha Piratvisuth – 24 May 2021
Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective
Tung‐Hung Su, Jia‐Horng Kao – 24 May 2021
NAFLD in Lean Asians
Mohammed Eslam, Fei Chen, Jacob George – 24 May 2021
Factores de riesgo de la enfermedad por hígado graso no alcohólico en poblaciones de Latinoamérica: situación actual y perspectivas
Claudia Pinto Marques Souza Oliveira, Helma Pinchemel Cotrim, Marco Arrese – 24 May 2021
¿Qué estrategias deben implementarse en Latinoamérica para erradicar el virus de la hepatitis C antes de 2030?
Ezequiel Ridruejo, y Alejandro Soza – 24 May 2021
Barriers and Limitations to Access to Liver Transplantation in Latin America
Wellington Andraus – 24 May 2021
Life After s Loss: Impact of Hepatitis B s Antigen Loss on Future Patient Outcomes
Daniel Q. Huang, Seng Gee Lim – 24 May 2021
Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable
Radha K. Dhiman, Madhumita Premkumar – 24 May 2021
Heterogeneidad clínica y virológica de la hepatitis delta en la Amazonia: más preguntas que respuestas
Raymundo Paraná, y Flor H. Pujol – 24 May 2021
Affordability of Antiviral Therapy in Asia‐Pacific Countries and Its Impact on Public Health Outcomes
Prowpanga Udompap, Tawesak Tanwandee, Rino Gani – 24 May 2021